Press Releases

Date	Title	Company
20-Sep-2025	Red drop LAB. - a Swiss Startup Transforms Menstrual Blood Into an Innovative Diagnostic Tool	ACCESS Newswire
20-Sep-2025	Rosen Law Firm Urges Jasper Therapeutics, Inc. (NASDAQ: JSPR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights	Businesswire
20-Sep-2025	FDA Approves Merck’s KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) Injection for Subcutaneous Use in Adults Across Most Solid Tumor Indications for KEYTRUDA® (pembrolizumab)	Businesswire
19-Sep-2025	BioNxt Solutions Announces Closing of Shares for Debt Settlement	ACCESS Newswire
19-Sep-2025	aap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka Mierzejewska will leave the company at the end of the year	aap Implantate AG
19-Sep-2025	Terry Lynch Continues as Capital Markets Advisor and BioNxt Retains Investor Relations Professionals	ACCESS Newswire
19-Sep-2025	Advicenne Reports First Half Financial Results as of June 30, 2025, and Updates on Its Activities	Businesswire
19-Sep-2025	Onco-Innovations Commences Activities to Manufacture Nanoparticle Formulation with Dalton Pharma to Supply Preclinical Animal Studies	ACCESS Newswire
19-Sep-2025	JCR Pharmaceuticals and Alexion Achieve Milestone in Collaborative Neurodegenerative Disease Program	Businesswire
19-Sep-2025	Candid Therapeutics Recognized as a 2025 Endpoints 11 Honoree	Businesswire
19-Sep-2025	Shibuya Hoppmann Highlights FS-70 Scallop Centrifugal Feeder for High-Performance Packaging Applications	Shibuya Hoppmann
19-Sep-2025	No Difference in Transplant Outcomes Seen for Patients Unlikely to Find a Matched Unrelated Donor When a Donor Search Prognosis Strategy is Used	Businesswire
19-Sep-2025	xFOREST Therapeutics and Axcelead DDP Launch Joint Research Initiative on RNA Structure-Targeted Small Molecule Drug Discovery	Businesswire
19-Sep-2025	Moderna Announces First Made-in-Canada mRNA Vaccines Delivered to Canadian Provinces and Territories	ACCESS Newswire
19-Sep-2025	Asia-Pacific Robotic Neurosurgery Research and Forecast Report 2025-2035 \| Rapid Expansion Fueled by Healthcare Infrastructure Throughout Emerging APAC Markets - ResearchAndMarkets.com	Businesswire
19-Sep-2025	Celltrion announces commercial availability of Omlyclo™ across Europe at EADV 2025	Celltrion
19-Sep-2025	United Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso® in Idiopathic Pulmonary Fibrosis	Businesswire
19-Sep-2025	KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY® (sebetralstat), First and Only Oral On-Demand Treatment for Hereditary Angioedema	Businesswire
19-Sep-2025	Merck Receives Positive EU CHMP Opinion for ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) in Infants During Their First RSV Season	Businesswire
19-Sep-2025	Merck Receives Two Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab), for Subcutaneous (SC) Administration and for New Indication for Earlier-Stage Head and Neck Cancer	Businesswire